{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T09:12:33Z","timestamp":1773047553029,"version":"3.50.1"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1097\/hco.0b013e32801466e4","type":"journal-article","created":{"date-parts":[[2007,2,6]],"date-time":"2007-02-06T10:55:03Z","timestamp":1170759303000},"page":"133-138","source":"Crossref","is-referenced-by-count":17,"title":["Renal protective strategies in heart transplant patients"],"prefix":"10.1097","volume":"22","author":[{"given":"Marcelo","family":"Cantarovich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-15-20210204","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1053-2498(03)00147-5","article-title":"Analysis of survivors more than 10 years after heart transplantation in the cyclosporine era: Stanford experience","volume":"23","author":"Shiba","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"R2-15-20210204","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/00007890-199703150-00009","article-title":"Cyclosporine-associated end-stage nephropathy after cardiac transplantation: Incidence and progression","volume":"65","author":"Goldstein","year":"1997","journal-title":"Transplantation"},{"key":"R3-15-20210204","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000168677","article-title":"Time course of the decline in renal function in cyclosporine-treated heart transplant recipients","volume":"14","author":"Zietse","year":"1994","journal-title":"Am J Nephrol"},{"key":"R4-15-20210204","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/00007890-199010000-00012","article-title":"Cyclosporine nephrotoxicity in cardiac allograft patients \u2013 a seven-year follow-up","volume":"50","author":"Greenberg","year":"1990","journal-title":"Transplantation"},{"key":"R5-15-20210204","first-page":"708","article-title":"Influence on survival after heart transplantation of contraindications seen in transplant recipients","volume":"11","author":"Anguita","year":"1992","journal-title":"J Heart Lung Transplant"},{"key":"R6-15-20210204","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1600-6143.2006.01640.x","article-title":"Increased mortality in heart transplant patients with end-stage renal disease requiring chronic dialysis: the Canadian experience","volume":"7","author":"Alam","year":"2007","journal-title":"Am J Transplant"},{"key":"R7-15-20210204","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMoa021744","article-title":"Chronic renal failure after transplantation of a nonrenal organ","volume":"349","author":"Ojo","year":"2003","journal-title":"N Engl J Med"},{"key":"R8-15-20210204","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/S0041-1345(03)00524-4","article-title":"Impact of cardiac transplantation on kidney function: a single-center experience","volume":"35","author":"El Kossi","year":"2003","journal-title":"Transplant Proc"},{"issue":"Suppl 11","key":"R9-15-20210204","first-page":"168","article-title":"Early drop of creatinine clearance is a strong predictor of long-term renal dysfunction, chronic dialysis and mortality after heart transplantation [abstract]","volume":"5","author":"Cantarovich","year":"2005","journal-title":"Am J Transplant"},{"key":"R10-15-20210204","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1681\/ASN.V115951","article-title":"Predictors and evolution of renal function during 9 years following heart transplantation","volume":"11","author":"Lindelow","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"R11-15-20210204","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1016\/S0041-1345(02)03527-3","article-title":"Chronic renal failure after cardiac transplantation: predictive factors and influence on mortality \u2013 results of a monocenter study in 141 patients","volume":"34","author":"Veillon","year":"2002","journal-title":"Transplant Proc"},{"key":"R12-15-20210204","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1053-2498(03)00191-8","article-title":"Renal insufficiency and end-stage renal disease in the heart transplant population","volume":"23","author":"Rubel","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"R13-15-20210204","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000045534","article-title":"Risk factors for chronic renal dysfunction in cardiac allograft recipients","volume":"84","author":"Esposito","year":"2000","journal-title":"Nephron"},{"key":"R14-15-20210204","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-0012.2004.00105.x","article-title":"End-stage renal failure and cardiac mortality after heart transplantation","volume":"18","author":"Senechal","year":"2004","journal-title":"Clin Transplant"},{"key":"R15-15-20210204","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S1053-2498(01)00411-9","article-title":"The incidence of end-stage renal failure in 17 years of heart transplantation: a single center experience","volume":"21","author":"Satchithananda","year":"2002","journal-title":"J Heart Lung Transplant"},{"key":"R16-15-20210204","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1399-0012.1998.tb01098.x","article-title":"Two-hour cyclosporine level determination is the appropriate tool to monitor Neoral therapy","volume":"12","author":"Cantarovich","year":"1998","journal-title":"Clin Transplant"},{"key":"R17-15-20210204","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1097\/00007890-199911150-00023","article-title":"The temporal profile of calcineurin inhibition by cyclosporine in vivo","volume":"68","author":"Halloran","year":"1999","journal-title":"Transplantation"},{"key":"R18-15-20210204","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/00007890-200002150-00022","article-title":"Stimulated response of peripheral lymphocytes may distinguish cyclosporine effect in renal transplant recipients receiving a cyclosporine+rapamycin regimen","volume":"69","author":"Sindhi","year":"2000","journal-title":"Transplantation"},{"key":"R19-15-20210204","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1097\/00007890-199912270-00003","article-title":"Clinical benefit of neoral dose monitoring with cyclosporine 2-hr postdose levels compared with trough levels in stable heart transplant patients","volume":"68","author":"Cantarovich","year":"1999","journal-title":"Transplantation"},{"key":"R20-15-20210204","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.healun.2004.08.002","article-title":"Monitoring of cyclosporine 2-h postdose levels in heart transplantation: improvement in clinical outcomes","volume":"24","author":"Delgado","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"R21-15-20210204","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1432-2277.2004.00001.x","article-title":"C2 is superior to C0 as predictor of renal toxicity and rejection risk profile in stable heart transplant recipients","volume":"18","author":"Caforio","year":"2005","journal-title":"Transplant Int"},{"key":"R22-15-20210204","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1034\/j.1399-0012.2003.00036.x","article-title":"Impact of cyclosporine 2-h level and mycophenolate mofetil dose on clinical outcomes in de novo heart transplant patients receiving antithymocyte globulin induction","volume":"17","author":"Cantarovich","year":"2003","journal-title":"Clin Transplant"},{"issue":"Suppl 11","key":"R23-15-20210204","first-page":"249","article-title":"A 12-month, multicenter, randomized adaptive design, open-label study to evaluate the benefit of C2-hr monitoring of Neoral on safety and efficacy outcomes in de novo cardiac transplant recipients receiving basiliximab induction: 6-month results","volume":"5","author":"Cantarovich","year":"2005","journal-title":"Am J Transplant"},{"key":"R24-15-20210204","first-page":"587","article-title":"A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: heart rejection study group","volume":"9","author":"Billingham","year":"1990","journal-title":"J Heart Lung Transplant"},{"key":"R25-15-20210204","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.transproceed.2005.01.079","article-title":"C2 and C0 values for monitoring cyclosporine therapy in stable heart transplant recipients","volume":"37","author":"Diciolla","year":"2005","journal-title":"Transplant Proc"},{"key":"R26-15-20210204","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/00007691-199902000-00002","article-title":"Clinical pharmacokinetics of tacrolimus in heart transplant recipients","volume":"21","author":"Regazzi","year":"1999","journal-title":"Ther Drug Monit"},{"key":"R27-15-20210204","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/01.ftd.0000158080.61201.65","article-title":"Evaluation of a limited sampling strategy to estimate area under the curve of tacrolimus in adult renal transplant patients","volume":"27","author":"Armendariz","year":"2005","journal-title":"Ther Drug Monit"},{"key":"R28-15-20210204","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1016\/S0041-1345(03)00656-0","article-title":"Clinical pharmacokinetics of tacrolimus in heart transplantation: new strategies of monitoring","volume":"35","author":"Aumente Rubio","year":"2003","journal-title":"Transplant Proc"},{"key":"R29-15-20210204","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.healun.2004.12.112","article-title":"Best single time points to predict the area-under-the-curve in long-term heart transplant patients taking mycophenolate mofetil in combination with cyclosporine or tacrolimus","volume":"24","author":"Mardigyan","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"R30-15-20210204","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/j.1600-6143.2006.01290.x","article-title":"Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1-year report","volume":"6","author":"Kobashigawa","year":"2006","journal-title":"Am J Transplant"},{"key":"R31-15-20210204","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.healun.2005.11.452","article-title":"Five-year results of a randomized, single-center study of tacrolimus vs microemulsion cyclosporine in heart transplant patients","volume":"25","author":"Kobashigawa","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"R32-15-20210204","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0041-1345(00)00817-4","article-title":"Introduction of mycophenolate mofetil and cyclosporine withdrawal in heart transplant patients with progressive deteriorating renal function","volume":"32","author":"Dureau","year":"2000","journal-title":"Transplant Proc"},{"key":"R33-15-20210204","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1093\/ndt\/gfh957","article-title":"Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus","volume":"20","author":"Bumbea","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"R34-15-20210204","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1111\/j.1600-6143.2005.01055.x","article-title":"A randomized controlled trial of late conversion from CNI-based to sirolimus-based immunosuppression following renal transplantation","volume":"5","author":"Watson","year":"2005","journal-title":"Am J Transplant"},{"key":"R35-15-20210204","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1097\/01.tp.0000177644.45192.a3","article-title":"Switch from calcineurin inhibitors to sirolimus-induced renal recovery in heart transplant recipients in the midterm follow-up","volume":"81","author":"Bestetti","year":"2006","journal-title":"Transplantation"},{"key":"R36-15-20210204","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ejcts.2003.11.030","article-title":"Renal recovery after conversion to a calcineurin-free immunosuppression in late cardiac transplant recipients","volume":"25","author":"Groetzner","year":"2004","journal-title":"Eur J Cardiothorac Surg"},{"key":"R38-15-20210204","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJM199801153380304","article-title":"Interleukin-2 receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group","volume":"338","author":"Vincenti","year":"1998","journal-title":"N Engl J Med"},{"key":"R39-15-20210204","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0140-6736(97)09278-7","article-title":"Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 210 International Study Group","volume":"350","author":"Nashan","year":"1997","journal-title":"Lancet"},{"key":"R40-15-20210204","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1097\/00007890-200204150-00030","article-title":"Anti-CD25 monoclonal antibody coverage allows for calcineurin inhibitor \u2018holiday\u2019 in solid organ transplant patients with acute renal dysfunction","volume":"73","author":"Cantarovich","year":"2002","journal-title":"Transplantation"},{"issue":"Suppl 3","key":"R41-15-20210204","first-page":"552","article-title":"Calcineurin inhibitor substitution (\u2018retirement\u2019) with anti-CD25 monoclonal antibodies: a novel strategy in long-term heart transplant patients with progressive renal dysfunction","volume":"82","author":"Cantarovich","year":"2006","journal-title":"Transplantation"},{"key":"R42-15-20210204","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1523-1755.2005.00145.x","article-title":"Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: Pathophysiology and indications","volume":"67","author":"Wolf","year":"2005","journal-title":"Kidney Int"}],"container-title":["Current Opinion in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/HCO.0b013e32801466e4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T15:38:21Z","timestamp":1736782701000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001573-200703000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/hco.0b013e32801466e4","relation":{},"ISSN":["0268-4705"],"issn-type":[{"value":"0268-4705","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}